CymaBay Therapeutics (CBAY) Earnings Date, Estimates & Call Transcripts → Executive Order To Wipe Out Your Bank Accounts (From Oasis Gold) (Ad) Free CBAY Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrends Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCBAY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CBAY Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Paradigm PressTime is Running Out - June 25th Deadline Approaching!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.That will slam shut June 25. CymaBay Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243($0.35)($0.23)($0.30)Q2 20243($0.40)($0.24)($0.34)Q3 20243($0.47)($0.24)($0.38)Q4 20243($0.53)($0.24)($0.38)FY 202412($1.75)($0.95)($1.41) CymaBay Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript2/28/2024Q4 2023($0.31)($0.35)($0.04)($0.35)$0.42 million$0.06 million11/7/2023Q3 2023($0.30)($0.32)($0.02)($0.32)$0.22 million- 8/10/2023Q2 2023($0.21)($0.01)+$0.20($0.01)$30.78 million$31.02 million 5/15/2023Q1 2023($0.16)($0.29)($0.13)($0.29)--3/16/2023Q4 2022($0.30)($0.30)-($0.30)-- 11/14/2022Q3 2022($0.30)($0.28)+$0.02($0.28)--Prepare for a Recession Unlike Any Other (Ad)Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE8/11/2022Q2 2022($0.30)($0.31)($0.01)($0.31)-- 5/12/2022Q1 2022($0.31)($0.32)($0.01)($0.32)-- 3/17/2022Q4 2021($0.36)($0.34)+$0.02($0.34)-- 11/10/2021Q3 2021($0.26)($0.33)($0.07)($0.33)-- 8/12/2021Q2 2021($0.27)($0.34)($0.07)($0.34)-- 5/13/2021Q1 2021($0.24)($0.25)($0.01)($0.25)-- 3/24/2021Q4 2020($0.20)($0.23)($0.03)($0.23)-- 11/5/2020Q3 2020($0.17)($0.17)-($0.17)-- 8/10/2020Q2 2020($0.23)($0.16)+$0.07($0.16)-- 5/11/2020Q1 2020($0.31)($0.19)+$0.12($0.19)-- 3/12/2020Q4 2019($0.39)($0.43)($0.04)($0.28)-- 11/5/2019Q3($0.37)($0.38)($0.01)($0.38)-- 8/7/2019Q2 2019($0.37)($0.35)+$0.02($0.35)-- CymaBay Therapeutics Earnings - Frequently Asked Questions How much revenue does CymaBay Therapeutics generate each year? CymaBay Therapeutics (NASDAQ:CBAY) has a recorded annual revenue of $31.07 million. How much profit does CymaBay Therapeutics generate each year? CymaBay Therapeutics (NASDAQ:CBAY) has a recorded net income of -$105.37 million. CBAY has generated -$0.97 earnings per share over the last four quarters. What is CymaBay Therapeutics's EPS forecast for next year? CymaBay Therapeutics's earnings are expected to grow from ($1.38) per share to ($1.37) per share in the next year. More Earnings Resources from MarketBeat Related Companies: MIRM Earnings CDMO Earnings RIGL Earnings GTHX Earnings VTRS Earnings UTHR Earnings RDY Earnings SRPT Earnings CTLT Earnings ELAN Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New Heights This page (NASDAQ:CBAY) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dav...American Hartford Gold Group | SponsoredTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTime is Running Out - June 25th Deadline Approaching!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRIL...Paradigm Press | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding CymaBay Therapeutics, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share CymaBay Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
